Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation

Abstract

Epithelial cell adhesion molecule (EpCAM) is a membrane glycoprotein expressed on adenomatous and simple epithelia, where it is involved in homophilic adhesion at the basolateral membrane. Carcinomas strongly overexpress EpCAM through an, as yet, unknown mechanism. Interestingly, otherwise EpCAM-negative squamous epithelia are seen to express EpCAM concomitant with their transformation and de-differentiation. The amount of EpCAM and the number of expressing cells both increase with the grade of dysplasia. Despite an important amount of data correlating the expression of EpCAM with cellular proliferation and de-differentiation, such as the coexpression with Ki-67, a marker for proliferation, it is unknown whether EpCAM may directly contribute to carcinogenesis. Here, we show that EpCAM has a direct impact on cell cycle and proliferation, and the ability to rapidly upregulate the proto-oncogene c-myc and cyclin A/E. Human epithelial 293 cells as well as murine NIH3T3 fibroblasts expressing EpCAM had a decreased requirement for growth factors, enhanced metabolic activity and colony formation capacity. Importantly, the inhibition of EpCAM expression with antisense mRNA led to a strong decrease in proliferation and metabolism in human carcinoma cells. Moreover, domain swapping experiments demonstrated that the intracellular part of EpCAM is necessary and sufficient to transduce the effects described. Thus, the data presented here highlight the role of EpCAM, demonstrating for the first time a direct link to cell cycle and proliferation.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Amati B, Alevizopoulos K and Vlach J . (1998). Front Biosci, 3, D250–D268.

  • Balzar M, Briaire-de Bruijn IH, Rees-Bakker HA, Prins FA, Helfrich W, de Leij L, Riethmuller G, Alberti S, Warnaar SO, Fleuren GJ and Litvinov SV . (2001). Mol. Cell Biol., 21, 2570–2580.

  • Balzar M, Winter MJ, de Boer CJ and Litvinov SV . (1999). J. Mol. Med., 77, 699–712.

  • Bouchard C, Thieke K, Maier A, Saffrich R, Hanley-Hyde J, Ansorge W, Reed S, Sicinski P, Bartek J and Eilers M . (1999). EMBO. J., 18, 5321–5333.

  • Chaubal S, Wollenberg B, Kastenbauer E and Zeidler R . (1999). Anticancer Res., 19, 2237–2242.

  • Daksis JI, Lu RY, Facchini LM, Marhin WW and Penn LJ . (1994). Oncogene, 9, 3635–3645.

  • Dang CV . (1999). Mol. Cell Biol., 19, 1–11.

  • Dang CV, Resar LM, Emison E, Kim S, Li Q, Prescott JE, Wonsey D and Zeller K . (1999). Exp. Cell Res., 253, 63–77.

  • Davies DE and Chamberlin SG . (1996). Biochem. Pharmacol., 51, 1101–1110.

  • Field JK . (1992). Eur. J. Cancer B. Oral. Oncol., 28B, 67–76.

  • Galaktionov KX, Chen X and Beach D . (1996). Nature, 382, 511–517.

  • Gastl G, Spizzo G, Obrist P, Dunser M and Mikuz G . (2000). Lancet., 356, 1981–1982.

  • Gires O, Zimber-Strobl U, Gonnella R, Ueffing M, Marschall G, Zeidler R, Pich D and Hammerschmidt W . (1997). EMBO. J., 16, 6131–6140.

  • Hanahan D and Weinberg RA . (2000). Cell, 100, 57–70.

  • Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, Obaya AJ, O'Connell BC, Mateyak MK, Tam W, Kohlhuber F, Dang CV, Sedivy JM, Eick D, Vogelstein B and Kinzler KW . (2000). Proc. Natl. Acad. Sci. USA, 97, 2229–2234.

  • Litvinov SV, Balzar M, Winter MJ, Bakker HA, Briaire-de Bruijn IH, Prins F, Fleuren GJ and Warnaar SO . (1997). J. Cell Biol., 139, 1337–1348.

  • Litvinov SV, van Driel W, van Rhijn CM, Bakker HA, van Krieken H, Fleuren GJ and Warnaar SO . (1996a). Am. J. Pathol., 148, 865–875.

  • Litvinov SV, van Driel W, van Rhijn CM, Bakker HA, van Krieken H, Fleuren GJ and Warnaar SO . (1996b). Am. J. Pathol., 148, 865–875.

  • Maniatis T, Fritsch E and Sambrook J . (1989). Cold Spring Harbor Press: New York.

  • Meden H and Kuhn W . (1997). Eur. J. Obstet. Gynecol. Reprod. Biol., 71, 173–179.

  • Meyaard L, van der Vuurst de Vries AR, de Ruiter T, Lanier LL, Phillips JH and Clevers H . (2001). J. Exp. Med., 194, 107–112.

  • Mosmann T . (1983). J. Immunol. Methods, 65, 55–63.

  • Packeisen J, Kaup-Franzen C and Knieriem HJ . (1999). Hybridoma, 18, 37–40.

  • Pauli C, Munz M, Kieu C, Mack B, Breinl P, Wollenberg B, Lang S, Zeidler R and Gires O . (2003). Cancer Lett., 193, 25–32.

  • Perez-Roger I, Solomon DL, Sewing A and Land H . (1997). Oncogene, 14, 2373–2381.

  • Piyathilake CJ, Frost AR, Weiss H, Manne U, Heimburger DC and Grizzle WE . (2000). Hum. Pathol., 31, 482–487.

  • Riethmüller G, Schneider Gädicke E, Schlimok G, Schmiegel W, Raab R, Höffken K, Gruber R, Pichlmaier H, Hirche H, Pichlmayr R, Buggisch P, Witte J and the German Cancer Aid 17-1A study group. (1994). Lancet, 343, 1177–1183.

  • Rodrigo JP, Lazo PS, Ramos S, Alvarez I and Suarez C . (1996). Arch. Otolaryngol Head Neck. Surg., 122, 504–507.

  • Roh H, Pippin JA, Green DW, Boswell CB, Hirose CT, Mokadam N and Drebin JA . (2000). Oncogene, 19, 6138–6143.

  • Schuhmacher M, Kohlhuber F, Holzel M, Kaiser C, Burtscher H, Jarsch M, Bornkamm GW, Laux G, Polack A, Weidle UH and Eick D . (2001). Nucleic Acids Res., 29, 397–406.

  • Spizzo G, Obrist P, Ensinger C, Theurl I, Dunser M, Ramoni A, Gunsilius E, Eibl G, Mikuz G and Gastl G . (2002). Int. J. Cancer, 98, 883–888.

  • Sugden B and Mark W . (1977). J. Virol., 23, 503–508.

  • Tandon AK, Clark GM, Chamness GC and McGuire WL . (1990). Cancer. Res., 50, 3317–3321.

  • Zornig M and Evan GI . (1996). Curr. Biol., 6, 1553–1556.

Download references

Acknowledgements

We thank Rob Chapman, Wolfgang Hammerschmidt and Dirk Eick for critically reading the manuscript. Part of the work was supported by the German Cancer Aid.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olivier Gires.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Münz, M., Kieu, C., Mack, B. et al. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 23, 5748–5758 (2004). https://doi.org/10.1038/sj.onc.1207610

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207610

Keywords

This article is cited by

Search

Quick links